12th World Apheresis Association 7th International Society for Apheresis Congress, March 17, 18, 19 & 20, 2009

12th World Apheresis Association 7th International Society for Apheresis Congress, March 17, 18, 19 & 20, 2009

Available online at www.sciencedirect.com Transfusion and Apheresis Science 39 (2008) 271 intl.elsevierhealth.com/journals/tras 12th World Apheresis...

132KB Sizes 21 Downloads 152 Views

Available online at www.sciencedirect.com

Transfusion and Apheresis Science 39 (2008) 271 intl.elsevierhealth.com/journals/tras

12th World Apheresis Association and 7th International Society for Apheresis Congress March 17, 18, 19 & 20 of 2009 AUDITORIOBUENOSAIRES. Bs.As.2501 Pueyrredon Avenue, Buenos Aires City, Buenos Aires, Argentina President for WAA President for ISFA Mario Figueroa, MD Andre Kaplan, MD E-mail [email protected] Web mail www.waa-isfa2009argentina.com

Speakers AUSTRIA Paul Hocker

Peter Ivanovich S. Siami Ghodrat Siami P.Schuff-Werner

CANADA Gail Rock CHINA Jun Xue Qiang Dong EEUU Andre Kaplan Paul Malchesky

FRANCE Paul Coppo GERMANI Wolfgang Ramlow MD. Vogt

ITALY MD. Ramunni JAPAN Noritoshi Shibuya Horshi Tsuda Akiyasu Baba Tatssuya Ide Takayuki Matsumoto Ken Yamaji Tadao Akizawa Y. Endo T. Abe

URUGUAY Jorge Decaro Ernesto Novoa USA Christina Anderson Dobry Kiprov Sergio Torloni Robert Weinstein

TOPIC PRELIMINARY PROGRAM

Pre- Congress Education for Technicians Symposium GLHEMA Congress SYMPOSIUM "Therapeutic Apheresis in Japan at the front" - Cardiodepressant IgG3 autoantibody elimination by immunoadsorption in patients with dilated cardiomyopathy - Novel therapeutic strategy for chronic hepatitis C - Double filtration plasmapheresis and (PEG) interferon/ribavirin combination therapy - Leukocytapheresis as a therapeutic option for intractable inflammatory bowel disease -Therapeutic apheresis in the neurological disorders - Therapeutic Apheresis for Rheumatic Disease

doi:10.1016/j.transci.2008.09.015

Apheresis Activities Around the World - 2009 Update Registries + Regulatory Issues / Reimbursement (ISFA) Regulatory Issues / Reimbursement Cardiovascular diseases I (LDL + Rheo) Cardiovascular diseases II (Cardiomyopathy “A Comparison of Pathogen Inactivated Plasmas for use in plasma exchange” Inflammatory Bowel Diseases Autoimmune diseases Septic shock and liver failure PTT/HUS Transplantation Hemorragic disorder Autotransfusion